Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

New SERMs discovered at Lilly and claimed for estrogen-dependent disorders

May 13, 1998

Pfizer prepares new beta3-adrenoceptor agonists

May 13, 1998

Novartis begins phase III trial with Aredia in prostate cancer patients

May 12, 1998

Cysteine protease inhibitors synthesized at SKB claimed for osteoporosis, arthritis, periodontitis

May 11, 1998

Initial results in the development of gene therapy for OI reported by NIH

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

May 8, 1998

Osiris awarded patent for the use of MSCs in bone marrow regeneration

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

ArQule and Beth Israel enter collaboration for osteopenic disease drug discovery

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...